Supplementation With Spirulina Reduces Infarct Size and Ameliorates Cardiac Function in a Pig Model of STEMI

Background and Aims: Myocardial infarction (MI) is the clinical manifestation of atherosclerotic coronary artery disease. Spirulina is an algae known to ameliorate cardiometabolic disorders and with proven anti-inflammatory and anti-oxidant effects. We investigated, in a highly translatable animal m...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Gemma Vilahur, Pablo Sutelman, Soumaya Ben-Aicha, Guiomar Mendieta, Monika Radiké, Leonie Schoch, Laura Casaní, María Borrell-Pagés, Teresa Padro, Lina Badimon
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Frontiers Media S.A. 2022-05-01
Sarja:Frontiers in Pharmacology
Aiheet:
spirulina
STEMI
cardioprotection
antioxidation
anti-inflammatory
anti-apoptotic
Linkit:https://www.frontiersin.org/articles/10.3389/fphar.2022.891801/full
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
Lataa...

Samankaltaisia teoksia